NIH Grants Policy Under the Second Trump Administration

Source-supplied fields

Report metadata

Identifier

IF13131

Version

5

Product type

Resources

Status

Active

Published

Apr 17, 2026

Source updated

Apr 25, 2026, 3:37 pm UTC

Authors: Kavya Sekar

Source topics: National Institutes of Health (NIH) R&D, FDA Product Regulation & Medical Research, Health & Medical R&D

Politically.com intentionally does not reproduce the report summary or full text. Use the official Congress.gov links above to read the product in its source context.

Structured Congress.gov references

Related federal bills

• HR 5609To direct the National Institutes of Health to reinstate funding to recipients of grants or other awards, and for other purposes.
  119th Congress
• HR 4007To unfreeze and release funding for grant agreements of the National Institutes of Health, prohibit termination of such agreements for active and ongoing research, require the inclusion of termination clauses in such agreements, and prohibit termination of such agreements for no longer effectuating program goals or agency priorities.
  119th Congress
• HR 2855To limit the impoundment, transfer, or reprogramming of Federal funds made available for the National Institutes of Health, and for other purposes.
  119th Congress
• HR 420To impose limitations on the amount of indirect costs allowable under Federal research awards to institutions of higher education, and for other purposes.
  119th Congress
• HR 7173To amend the Public Health Service Act to ensure scientific integrity in the activities of the National Institutes of Health and prevent the diversion of funds to politically driven activities, and for other purposes.
  119th Congress